The Bezos family has committed $710.5 million to Fred Hutchinson Cancer Center over the next 10 years—likely the largest single private contribution made to a cancer center in the U.S.
In the late 1960s, NCI received the modern-day equivalent of billions of dollars to establish a viral oncology program. At the time, the study of the role viruses played in cancer (or whether they played any role at all) was unknown. This could have been either a triumph or a huge and embarrassing waste of... […]
Patient navigation didn’t start out as a business idea. The concept—and the adaptation of the nautical term—are attributed to the surgeon Harold Freeman, when he started to practice in Harlem after finishing his residency at Memorial Sloan Kettering Cancer Center in 1968. “If people meet barriers in getting through the healthcare system with cancer and... […]
As Ben Ho Park sees it, the mission of a cancer researcher doesn’t stop at the water’s edge. It follows that Park’s new role as director of Vanderbilt-Ingram Cancer Center is inseparable from his role as an executive of the Global Cancer Institute, a nonprofit that works with healthcare providers in low- and middle-income countries to improve survival rates for underserved cancer patients.
Up to 15% of U.S. counties—home to about 25 million Americans—fall outside the reach of the catchment area of this country’s cancer centers.
Andrew Chapman is the first geriatric oncology expert to run an NCI-designated cancer center. Ever.
Companies vying for accelerated approval and devising strategies for confirmatory trials would be best served by seeking prospective sign-off from FDA, agency officials say. Officials from the FDA Oncology Center of Excellence described these best practices in a perspective piece in the Sept. 21 issue of The New England Journal of Medicine and discussed the […]
Dwight Tosh had grown so weak that he was unable to walk. Still, doctors at the rural Arkansas hospital—where he lay in bed for weeks in 1962—were unable to diagnose him.
Augusto C. Ochoa’s introduction to NCI community research had the feel of a battlefield commission. In the aftermath of the 2005 Hurricane Katrina, the PI of what was then the Community Clinical Oncology Program informed Ochoa, that she would be leaving Louisiana State University.
As real-world evidence becomes ever more essential, a cancer health technology company that played a key role in modernizing 21st-century health data is capitalizing on its accomplishments in the U.S.—and moving into international markets to meet the growing demand for actionable data.
